BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,870.00
+110.00 (1.91%)
Feb 21, 2025, 9:00 AM KST
-48.19%
Market Cap 28.16B
Revenue n/a
Net Income n/a
Shares Out 4.80M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend 600.00 (10.85%)
Ex-Dividend Date Dec 27, 2024
Volume 9,559
Average Volume 55,679
Open 5,770.00
Previous Close 5,760.00
Day's Range 5,710.00 - 5,890.00
52-Week Range 5,390.00 - 11,580.00
Beta n/a
RSI 48.36
Earnings Date n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

News

There is no news available yet.